| Risk factor | Malaria parasitaemia | OR | 95% CI | χ2 | p value | |
| Present N (%) | Absent N (%) | |||||
| SEC |
|
|
|
|
|
|
| Lower(IV and V) | 11 (3.7) | 210 (69.8) | 0.79 | 0.27 - 2.35 | 0.189 | 0.664 |
| Upper (I-III) | 5 (1.6) | 75 (24.9) |
|
|
|
|
| Maternal age |
|
|
|
|
|
|
| <29 years | 6 (2.0) | 132 (43.9%) | 0.70 | 0.24 - 2.03 | 0.474 | 0.609 |
| ≥29 years | 10 (3.3) | 153 (50.8%) |
|
|
|
|
| Parity |
|
|
|
|
|
|
| 1 | 5 (1.7) | 123 (40.5) | 0.61 | 0.23 - 1.82 | 0.830 | 0.360 |
| >1 | 11 (3.7) | 162 (54.2) |
|
|
|
|
| Sex |
|
|
|
|
|
|
| Female | 7 (2.3) | 101 (33.6) | 1.42 | 0.43 - 4.42 | 0.455 | 0.501 |
| Male | 9 (3.0) | 184 (61.1) |
|
|
|
|
| Gestational age |
|
|
|
|
|
|
| Preterm (28 - 36 weeks) | 14 (4.7) | 218 (72.4) | 2.15 | 0.47 - 19.94 |
| 0.540# |
| Term (37 - 42 weeks) | 2 (0.7) | 67 (22.3) |
|
|
|
|
| IPT-SP |
|
|
|
|
|
|
| <2 doses | 5 (1.9) | 122 (40.5) | 0.625 | 0.22 - 1.89 | 0.782 | 0.362 |
| ≥2 doses | 11 (4.1) | 163 (54.2) |
|
|
|
|
| Use of ITN |
|
|
|
|
|
|
| Always | 4 (1.3) | 152 (50.4) | 0.296 | 0.09 - 0.90 |
| 0.025#* |
| Not always | 12 (4.0) | 133 (44.2) |
|
|
|
|
| Maternal HIV |
|
|
|
|
|
|
| Reactive | 1 (0.3) | 13 (4.3) | 1.39 | 0.03 - 10.55 |
| 0.543# |
| Non reactive | 15 (5.2) | 272 (90.4) |
|
|
|
|